文献速递慢阻肺

COPD患者心血管事件:心脏风险评分与冠状动脉钙化评分的互补作用

Cardiovascular Events in COPD: Complementary Role of Cardiac Risk and Coronary Artery Calcium Scores.
PubMed 文献 · Chest · 2025-10-14

本研究为观察性队列,纳入529例COPD患者,计算心血管风险评分(CVRS)与冠状动脉钙化评分(CACS),按CVRS≥10%或CACS>3分为4组,中位随访98个月。结果显示131例(24%)发生主要不良心血管事件(MACE),联合CVRS与CACS预测MACE的AUC为0.72,优于单独CVRS(0.69)或CACS(0.66)。结论认为两者联合对COPD患者MACE风险分层具有互补作用。

要点

  • COPD患者中位随访98个月,24%发生MACE。
  • CVRS≥10%且CACS>3组MACE风险比为7.6(95%CI 4.9-11.9)。
  • CVRS联合CACS预测MACE的AUC为0.72,优于单一评分。

核心结论

  • 心血管风险评分与冠状动脉钙化评分联合对COPD患者MACE风险分层具有互补作用。

研究设计与样本

  • 观察性队列研究,纳入529例COPD患者,均接受胸部CT扫描并记录临床、功能及实验室数据。
  • 计算CACS及CVRS(SCORE2、SCORE2-OP、SCORE2-Diabetes、SMART风险评分),以CVRS≥10%或CACS>3分为4组,中位随访98个月。

主要发现

  • 131例患者(24%)发生MACE。
  • 与组I(CVRS<10%且CACS≤3)相比,组IV(CVRS≥10%且CACS>3)MACE风险比为7.6(95%CI 4.9-11.9;P<.001)。
  • 组III(CVRS<10%且CACS>3)风险比为3.1(95%CI 1.8-8.5;P<.001)。
  • 组II(CVRS≥10%且CACS≤3)风险比为2.6(95%CI 1.6-4.2;P<.001)。
  • 预测MACE的ROC曲线下面积:CACS联合CVRS为0.72(P<.01),CVRS为0.69,CACS为0.66。

关键数值与推荐

  • 分组阈值:CVRS≥10%或CACS>3。
  • 组I:CVRS<10%且CACS≤3;组II:CVRS≥10%且CACS≤3;组III:CVRS<10%且CACS>3;组IV:CVRS≥10%且CACS>3。
  • 预测MACE的AUC:联合评分0.72,CVRS 0.69,CACS 0.66。

临床怎么用

  • 对COPD患者可联合评估CVRS与CACS以改善MACE风险分层。
  • CACS>3且CVRS≥10%的患者MACE风险最高,需加强心血管风险管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with COPD are at high risk of major adverse cardiovascular events (MACEs) developing. Existing clinical tools for risk stratification in these patients have underperformed in predicting the outcomes. RESEARCH QUESTION: Does a combination of cardiovascular risk score (CVRS) and coronary artery calcium score (CACS) improve risk assessment of MACEs in patients with COPD? STUDY DESIGN AND METHODS: This was an observational cohort of patients with COPD (n = 529). They underwent a chest CT scan, and clinical, functional, and laboratory data were recorded. The CACS and CVRS (Systematic Coronary Risk Evaluation [SCORE] 2, SCORE2-Older People [OP], SCORE2-Diabetes, and Secondary Manifestations of Arterial Disease [SMART] risk scores) were calculated. Using a threshold of CVRS of ≥ 10% or CACS score of > 3, patients were divided into 4 groups-group I, CVRS < 10% and CACS ≤ 3; group II, CVRS ≥ 10% and CACS ≤ 3; group III, CVRS < 10% and CACS > 3; and group IV, CVRS ≥ 10% and CACS > 3-who were followed up for a median of 98 months. Regression analysis and Kaplan Meier curves were used to compare the risks among groups. Receiver operating characteristic (ROC) curve analysis determined the performance of CACS and CVRS and their combination to predict MACEs. RESULTS: Most patients were male (80%) with moderate COPD. Over time, 131 patients (24%) experienced a MACE. Compared with group I, the hazard ratios for MACEs were: group IV, 7.6 (95% CI, 4.9-11.9; P < .001); group III, 3.1 (95% CI, 1.8-8.5; P < .001); and group II, 2.6 (95% CI, 1.6-4.2; P < .001). The areas under the ROC curve for predicting MACEs were 0.72 (P < .01) for CACS plus CVRS compared with 0.69 for CVRS and 0.66 for CACS. CONCLUSIONS: The combination of cardiovascular risk and coronary artery calcification scores were shown to provide a complementary role in MACE risk stratification in patients with COPD.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. de-Torres JP, Casanova C, Zagaceta J, et al. Cardiovascular Events in COPD: Complementary Role of Cardiac Risk and Coronary Artery Calcium Scores. Chest. 2025. PMID: 41101639. doi:10.1016/j.chest.2025.09.133

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。